Methylprednisolone sodium succinate and Hyperpyrexia - a phase IV clinical study of FDA data

Summary:

Hyperpyrexia is reported as a side effect among people who take Methylprednisolone sodium succinate (methylprednisolone sodium succinate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Hyperpyrexia when taking Methylprednisolone sodium succinate. It is created by eHealthMe based on reports of 18,153 people who have side effects when taking Methylprednisolone sodium succinate from the FDA, and is updated regularly.

What is Methylprednisolone sodium succinate?

Methylprednisolone sodium succinate has active ingredients of methylprednisolone sodium succinate. eHealthMe is studying from 18,163 Methylprednisolone sodium succinate users. Check the latest studies of Methylprednisolone sodium succinate.

What is Hyperpyrexia?

Hyperpyrexia (extremely high fever) is found to be associated with 378 drugs and 528 conditions by eHealthMe. Check the latest studies of Hyperpyrexia.

On Jul, 09, 2026

18,153 people reported to have side effects when taking Methylprednisolone sodium succinate.
Among them, 15 people (0.08%) have Hyperpyrexia.

Could Methylprednisolone sodium succinate cause Hyperpyrexia?

Among these 15 people:

How long have people been on Methylprednisolone sodium succinate when they have Hyperpyrexia? *

What is the gender of people who have Hyperpyrexia when taking Methylprednisolone sodium succinate? *

female: 53.33 %
male: 46.67 %

What is the age of people who have Hyperpyrexia when taking Methylprednisolone sodium succinate? *

What are other drugs people take besides Methylprednisolone sodium succinate? *

What are other side effects people have besides Hyperpyrexia? *

Chills (felling of cold): 7 people, 46.67%
Chest Pain: 4 people, 26.67%
Weakness: 4 people, 26.67%
Temperature Intolerance (inability to go in temperature): 3 people, 20.00%
Discomfort: 2 people, 13.33%
Mucosal Inflammation (infection of mucous membrane): 2 people, 13.33%
Melaena (the passage of black, tarry stools): 2 people, 13.33%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 13.33%
Joint Pain: 2 people, 13.33%
Intestinal Obstruction: 2 people, 13.33%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 26.67%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 20.00%
Osteoporosis (bones weak and more likely to break): 2 people, 13.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 6.67%
Hypersensitivity: 1 person, 6.67%
Encephalitis Autoimmune (autoimmune origin disturbances of consciousness and pyramidal signs, inflammation of the brain): 1 person, 6.67%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone sodium succinate and have Hyperpyrexia?

- Check whether Hyperpyrexia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methylprednisolone sodium succinate:

Methylprednisolone sodium succinate (18,163 reports)

Hyperpyrexia treatments and more:

Hyperpyrexia (4,941 reports)

How severe was Hyperpyrexia and when was it recovered:

Hyperpyrexia in Methylprednisolone sodium succinate

Expand to all the drugs that have ingredients of methylprednisolone sodium succinate:

Hyperpyrexia and drugs with ingredients of methylprednisolone sodium succinate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylprednisolone sodium succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperpyrexia:

Hyperpyrexia (378 drugs)

Browse all the conditions that are associated with Hyperpyrexia:

Hyperpyrexia (528 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone sodium succinate (the active ingredients of Methylprednisolone sodium succinate) and Methylprednisolone sodium succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.